Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nematode Infection Controls Obesity and Modulates Body Weight and Metabolism

By LabMedica International staff writers
Posted on 09 May 2013
In an interesting combination of low and high technology approaches to the control and treatment of obesity, a recent study suggested that infection with parasitic nematodes (roundworms) could suppress the chronic inflammation associated with obesity and modulate body weight and metabolism.

Obesity is associated with a chronic low-grade inflammation characterized by increased levels of proinflammatory cytokines that are implicated in metabolic dysfunction. More...
Nematode infection, which elevates host immune Th2-cells and related type two cytokines, has been used in ancient medicine and is currently under clinical investigation for treatment for diseases associated with the relevant cytokines, including inflammatory bowel disease, multiple sclerosis, and allergies

Investigators at the University of Maryland School of Medicine (Baltimore, USA) examined the possibility of using nematode infection to treat obesity. They worked with several strains of mice that were fed normal or high-fat diets.

They reported in the March 18, 2013, online edition of the journal Infection and Immunity that normal size mice infected with the nematode Nippostrongyrus brasiliensis fed a high-fat diet gained 15% percent less weight than control animals that were not infected. Mice that were already obese when infected lost roughly 13% of their body weight within 10 days. Infected animals were found to have decreased fasting blood glucose levels and reduced incidence of fatty liver disease.

"The levels of insulin and leptin also dropped, indicating that the mice restored their sensitivities to both hormones," said senior author Dr. Aiping Zhao, associate professor of radiation oncology at the University of Maryland School of Medicine. "Leptin moderates appetite. As with too much insulin, too high a level of leptin results in insensitivity, thus contributing to obesity and metabolic syndrome."

Related Links:

University of Maryland School of Medicine



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.